Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma
/in Dendritic Cells, Exosome, International Publications, Malignant Pleural Mesothelioma /von 2013-10-24 / J Extracell Vesicles 2013;2Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-10-21 / Neurol. Med. Chir. (Tokyo) 2013;53(11):741-54Exploiting dendritic cells in the development of cancer vaccines
/in Dendritic Cells, International Publications /von 2013-10-04 / Expert Rev Vaccines 2013 Oct;12(10):1195-210Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-10-01 / Immunotherapy 2013 Oct;5(10):1043-6Temperature matters! And why it should matter to tumor immunologists
/in Hyperthermia, International Publications /von 2013-10-01 / Cancer Immunol Res 2013 Oct;1(4):210-6Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2013-10-01 / Immunotherapy 2013 Oct;5(10):1039-42A review of dendritic cell therapy for cancer: progress and challenges
/in Dendritic Cells, International Publications /von 2013-10-01 / BioDrugs 2013 Oct;27(5):453-68Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes
/in Exosome, International Publications /von 2013-09-12 / J Extracell Vesicles 2013;2Oncolytic viruses as therapeutic cancer vaccines
/in International Publications, Newcastle Disease Virus /von 2013-09-11 / Mol. Cancer 2013 Sep;12(1):103
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de